Zoledronic acid is a drug used as part of treatment of cancer patients to reduce or delay bone complications from bone metastases. Researchers found that response to this treatment may be influenced by a patient’s vitamin D status. Researchers from the University of Sheffield in the United Kingdom have found that breast cancer patients who have insufficient vitamin D levels could have a worse prognosis after standard treatment with zoledronic acid than in patients with normal levels of vitamin D. On the other hand, postmenopausal women who have sufficient levels of the vitamin are less likely to experience breast cancer recurrence […]Continue reading Vitamin D Improves Bone Treatment Response in Breast Cancer Patients
Disclaimer: The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images and information, contained on or available through this web site is for general information purposes only. Natural Health Sherpa LLC makes no representation and assumes no responsibility for the accuracy of information contained on or available through this web site, and such information is subject to change without notice. You are encouraged to confirm any information obtained from or through this web site with other sources, and review all information regarding any medical condition or treatment with your physician.